Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEmpresaria Group Regulatory News (EMR)

Share Price Information for Empresaria Group (EMR)

Share Price is delayed by 15 minutes
Get Live Data
22.50    0.00 (0.00%)
Bid:
21.00
Ask:
24.00
Spread: 3.00 (14.286%)
Market Cap: £11.04m
EMR Live PriceLast checked at - London Stock Exchange

Intraday Empresaria Group Share Chart

Trading Update

24 Jan 2018 07:00

RNS Number : 7180C
Empresaria Group PLC
24 January 2018
 

24 January 2018

 

Empresaria Group plc ("Empresaria" or the "Group")

Trading Update

Record profit, in line with market expectations

 

Empresaria (AIM: EMR), the international specialist staffing group, today announces a trading update for the financial year ended 31 December 2017, ahead of announcing its final results on Wednesday 14 March 2018.

 

The Board is pleased to advise that full year profitability will be in line with current market expectations. The Group is expected to deliver a record adjusted profit before tax, up approximately 20% year on year. We expect net fee income to be approximately 17% ahead of the prior year and diluted adjusted earnings per share up approximately 9% on the prior year.

There were strong performances in the UK within professional services and other services (domestic services and new house sales), in Japan in IT & design and in Chile in retail. The technical & industrial sector experienced a challenging year. The Group has worked to minimize the impact of changes to temporary worker legislation in Germany and the business in the Middle East has been resized resulting in an improved performance.

We are pleased with how well our recent investments have integrated into the Group, including an improved performance from our businesses in the USA in the second half. We continue to build on the strengths of our Group, investing in our existing brands and identifying further potential external investments.

 

Joost Kreulen, Chief Executive of Empresaria, said:

"Empresaria has demonstrated the benefit of its diversified business model, delivering another record profit in 2017. We are focused on delivering our strategy: strengthening a multi-branded group, with a focus on developing leading brands that are diversified and balanced by geography and sector."

 

Enquiries:

Empresaria Group plcJoost Kreulen, Chief Executive OfficerSpencer Wreford, Group Finance Director & Chief Operating Officer

via Alma

Arden Partners (Nominated Adviser and Broker)John Llewellyn-Lloyd / Steve Douglas / Ciaran Walsh

020 7614 5900

Alma PR (Financial PR)Hilary Buchanan

020 8004 4217empresaria@almapr.com

 

Notes for editors:

 

· Empresaria Group plc is an international specialist staffing group with 18 brands operating in 20 countries across the globe including the UK, Germany, Japan, India, UAE, Indonesia, Chile, Australia, Thailand, Singapore, Finland, USA, New Zealand, China, Malaysia, Vietnam and the Philippines.

· Empresaria offers temporary/contract and permanent staffing solutions as well as offshore recruitment services in seven key sectors: technical & industrial, aviation services, IT & design, professional services, healthcare, executive search and retail.

· Empresaria applies a multi brand, management equity philosophy and business model, with Empresaria group company management teams holding significant equity in their own business.

· Empresaria is listed on AIM under ticker EMR. For more information: empresaria.com

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTLLFFDLAIVFIT
Date   Source Headline
7th Sep 20237:00 amRNSTransaction in Own Shares
25th Aug 20237:00 amRNSPDMR Dealing, Exercise of Share Options
22nd Aug 20237:00 amRNSInterim Results
15th Aug 20237:00 amRNSLaunch of LMA Recruitment in the US
27th Jul 20237:00 amRNSTrading Update and Notice of Results
19th Jun 20238:20 amRNSTransaction in Own Shares
6th Jun 20237:00 amRNSTransaction in Own Shares
23rd May 20231:18 pmRNSResult of AGM
23rd May 20237:00 amRNSTrading Update
16th May 20237:00 amRNSTransaction in Own Shares
2nd May 20236:25 pmRNSDirector/PDMR Shareholding
2nd May 20234:26 pmRNSTransaction in Own Shares
28th Apr 20233:50 pmRNSPDMR Dealing, Exercise of Share Options
26th Apr 20237:00 amRNSCompany LTIP Awards
20th Apr 20237:00 amRNSAnnual Report and Accounts and Notice of AGM
30th Mar 202310:15 amRNSTransaction in Own Shares
28th Mar 20237:00 amRNSFinal Results
20th Mar 20233:05 pmRNSNotice of Investor Presentation
20th Feb 20237:00 amRNSAppointment of Independent Non-Executive Director
26th Jan 20237:00 amRNSTrading Update
16th Jan 20237:00 amRNSAppointment of Independent Non-Executive Director
15th Dec 20222:49 pmRNSTransaction in Own Shares
14th Dec 20227:00 amRNSTransaction in Own Shares
12th Dec 20227:18 amRNSTransaction in Own Shares
7th Dec 20228:34 amRNSTransaction in Own Shares
2nd Dec 20227:00 amRNSTransaction in Own Shares
29th Nov 20227:00 amRNSAppointment of Joint Broker
9th Nov 20228:24 amRNSTransaction in Own Shares
4th Nov 20227:00 amRNSTransaction in Own Shares
24th Oct 20227:00 amRNSDirector/PDMR Shareholding
14th Oct 20223:25 pmRNSDirector/PDMR Shareholding
13th Oct 20227:00 amRNSCapital Markets Day
6th Oct 20225:10 pmRNSTransaction in Own Shares
4th Oct 20228:13 amRNSTransaction in Own Shares
1st Sep 202212:23 pmRNSTransaction in Own Shares
12th Aug 20227:00 amRNSTransaction in Own Shares
11th Aug 20227:00 amRNSInterim Results
28th Jul 20227:00 amRNSTrading Update and Notice of Results
20th Jun 202210:54 amRNSTransaction in Own Shares
14th Jun 20229:16 amRNSTransaction in Own Shares
7th Jun 202211:44 amRNSDirector/PDMR Shareholding
7th Jun 202211:37 amRNSTransaction in Own Shares
6th Jun 20227:00 amRNSBoard Update
18th May 20221:40 pmRNSTransaction in Own Shares
17th May 20228:33 amRNSTransaction in Own Shares
12th May 20224:11 pmRNSResult of AGM
12th May 20223:20 pmRNSTransaction in Own Shares
12th May 20227:00 amRNSTrading Update
11th May 20225:09 pmRNSTransaction in Own Shares
10th May 20222:21 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.